- Home
- CMMB vs YMAT Comparison
CMMB vs YMAT Comparison
Compare CMMB & YMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CMMB | YMAT |
|---|---|---|
| Founded | 2004 | 1970 |
| Country | Israel | Taiwan |
| Employees | N/A | 65 |
| Industry | Biotechnology: Pharmaceutical Preparations | Recreational Games/Products/Toys |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.8M | 9.9M |
| IPO Year | 2023 | N/A |
Fundamental Metrics
Financial Performance| Metric | CMMB | YMAT |
|---|---|---|
| Price | $2.25 | $0.52 |
| Analyst Decision | Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $25.00 | N/A |
| AVG Volume (30 Days) | 104.3K | ★ 6.2M |
| Earning Date | 05-21-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 101.67 | N/A |
| EPS | ★ 0.04 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $56.75 | ★ $10.92 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.87 | $0.24 |
| 52 Week High | $3.86 | $6.45 |
Technical Indicators
Market Signals| Indicator | CMMB | YMAT |
|---|---|---|
| Relative Strength Index (RSI) | 74.41 | 44.07 |
| Support Level | $1.48 | $0.33 |
| Resistance Level | $2.80 | $0.63 |
| Average True Range (ATR) | 0.17 | 0.12 |
| MACD | 0.05 | -0.02 |
| Stochastic Oscillator | 84.04 | 21.22 |
Price Performance
Historical ComparisonAbout CMMB Chemomab Therapeutics Ltd.
Chemomab Therapeutics Ltd is a clinical-stage biotechnology company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin, and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life-threatening fibrotic and inflammatory diseases.
About YMAT J-Star Holding Co. Ltd. Ordinary Shares
J-Star Holding Co Ltd is engaged in the research, development, and manufacturing of carbon fiber for a wide variety-of-products including carbon bicycles, carbon rackets, automotive parts, outdoor sports gears, and healthcare products. The company has five segments: Bicycle frame, Racket, Crank, Service provision, and Others. The majority of its revenue is generated from the Bicycle frame segment. Geographically, the company operates in Taiwan, China, and other regions.